NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Arne Yndestad's publications

Publications by Arne Yndestad

121 publications found

Publications in press

  1. Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GO, Aukrust P, Valen G, Vinge LE
    Increased circulating mitochondrial DNA after myocardial infarction
    Int J Cardiol (in press)
    PubMed 22578950
  2. Orn S, Ueland T, Manhenke C, Sandanger O, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P
    Increased interleukin-1? levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
    J Intern Med (in press)
    PubMed 22243053

Publications 2012

  1. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
    Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
    J Acquir Immune Defic Syndr, 59 (2), e24-5
    PubMed 22245717
  2. Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2012)
    Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
    Eur J Endocrinol, 166 (3), 503-10
    PubMed 22170794
  3. Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A (2012)
    The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
    J Intern Med, 271 (5), 436-443
    PubMed 22211640
  4. Sikkeland LI, Dahl CP, Ueland T, Andreassen AK, Gude E, Edvardsen T, Holm T, Yndestad A, Gullestad L, Kongerud J, Aukrust P, Oie E (2012)
    Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
    PLoS One, 7 (5), e36815
    PubMed 22615818
  5. Ueland T, Yndestad A, Dahl CP, Gullestad L, Aukrust P (2012)
    TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
    Curr Heart Fail Rep, 9 (2), 92-100
    PubMed 22453763
  6. Waehre A, Vistnes M, Sjaastad I, Nygård S, Husberg C, Lunde IG, Aukrust P, Yndestad A, Vinge LE, Behmen D, Neukamm C, Brun H, Thaulow E, Christensen G (2012)
    Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
    J Appl Physiol, 112 (8), 1372-82
    PubMed 22345433
  7. Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P (2012)
    The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
    PLoS One, 7 (3), e33038
    PubMed 22427939

Publications 2011

  1. Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
    Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
    Heart, 97 (6), 460-5
    PubMed 21270073
  2. Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
    Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
    Diabetes, 60 (5), 1544-51
    PubMed 21464440
  3. Aukrust P, Sandberg WJ, Otterdal K, Vinge LE, Gullestad L, Yndestad A, Halvorsen B, Ueland T (2011)
    Tumor necrosis factor superfamily molecules in acute coronary syndromes
    Ann Med, 43 (2), 90-103
    PubMed 21039303
  4. Brun H, Ueland T, Thaulow E, Damas JK, Yndestad A, Aukrust P, Holmstrøm H (2011)
    No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts
    Congenit Heart Dis, 6 (4), 338-46
    PubMed 21450032
  5. Larsen KO, Yndestad A, Sjaastad I, Løberg EM, Goverud IL, Halvorsen B, Jia J, Andreassen AK, Husberg C, Jonasson S, Lipp M, Christensen G, Aukrust P, Skjønsberg OH (2011)
    Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
    Am J Physiol Lung Cell Mol Physiol, 301 (1), L50-9
    PubMed 21498626
  6. Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G (2011)
    Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
    PLoS One, 6 (4), e18668
    PubMed 21533157
  7. Yndestad A, Haukeland JW, Dahl TB, Halvorsen B, Aukrust P (2011)
    Activin A in nonalcoholic fatty liver disease
    Vitam Horm, 85, 323-42
    PubMed 21353887
  8. Øie E, Ueland T, Dahl CP, Bohov P, Berge C, Yndestad A, Gullestad L, Aukrust P, Berge RK (2011)
    Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality
    J Intern Med, 270 (3), 263-72
    PubMed 21466599

Publications 2010

  1. Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K (2010)
    Activated platelets and atherosclerosis
    Expert Rev Cardiovasc Ther, 8 (9), 1297-307
    PubMed 20828352
  2. Aukrust P, Yndestad A (2010)
    Inadequate Masking of Testosterone Reply
    J. Am. Coll. Cardiol., 55 (20), 2291
  3. Breland UM, Hollan I, Saatvedt K, Almdahl SM, Damås JK, Yndestad A, Mikkelsen K, Førre OT, Aukrust P, Ueland T (2010)
    Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
    Rheumatology (Oxford), 49 (6), 1118-27
    PubMed 20231178
  4. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, Ueland T, Yndestad A, Paulsson-Berne G, Damås JK, Oie E, Hansson GK, Halvorsen B, Aukrust P (2010)
    Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation
    Cardiovasc Res, 86 (2), 265-73
    PubMed 20139115
  5. Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
    Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
    J Clin Endocrinol Metab, 95 (6), 3039-47
    PubMed 20392873
  6. Yndestad A, Marshall AK, Hodgkinson JD, Tham el L, Sugden PH, Clerk A (2010)
    Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1
    Int J Biochem Cell Biol, 42 (2), 263-72
    PubMed 19861169
  7. Øie E, Ahmed MS, Ueland T, Sikkeland LI, Dahl CP, Hagelin EM, von Lueder T, Edvardsen T, Andreassen AK, Gullestad L, Aukrust P, Yndestad A, Vinge LE, Attramadal H (2010)
    Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
    Basic Res Cardiol, 105 (1), 89-98
    PubMed 19823891
  8. Øie E, Sandberg WJ, Ahmed MS, Yndestad A, Lærum OD, Attramadal H, Aukrust P, Eiken HG (2010)
    Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
    Scand Cardiovasc J, 44 (6), 359-66
    PubMed 20799913

Publications 2009

  1. Aukrust P, Ueland T, Gullestad L, Yndestad A (2009)
    Testosterone: a novel therapeutic approach in chronic heart failure?
    J Am Coll Cardiol, 54 (10), 928-9
    PubMed 19712803
  2. Brun H, Holmstrøm H, Thaulow E, Damås JK, Yndestad A, Aukrust P, Ueland T (2009)
    Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation
    Congenit Heart Dis, 4 (3), 153-9
    PubMed 19489942
  3. Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
    Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
    Circ Heart Fail, 2 (6), 624-32
    PubMed 19919988
  4. de Jager SC, Canté-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JM, Kuiper J, van Berkel TJ, Lipp M, Zwaginga JJ, Fibbe WE, Aukrust P, Biessen EA (2009)
    Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras
    Transplantation, 88 (5), 631-9
    PubMed 19741459
  5. Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
    Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
    Clin Immunol, 131 (3), 438-46
    PubMed 19232508
  6. Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
    Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
    Clin Immunol, 130 (2), 151-61
    PubMed 18938112
  7. Fevang B, Yndestad A, Damås JK, Halvorsen B, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
    Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation
    Clin Exp Immunol, 158 (2), 237-45
    PubMed 19747210
  8. Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Frøland SS, Olofsson PS, Damås JK, Gullestad L, Hansson GK, Oie E, Aukrust P (2009)
    Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
    Circ Res, 104 (1), 60-8
    PubMed 19023130
  9. Sandberg WJ, Otterdal K, Gullestad L, Halvorsen B, Ragnarsson A, Frøland SS, Damås JK, Oie E, Aukrust P, Hansson GK, Yndestad A (2009)
    The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
    Thromb Haemost, 102 (4), 704-10
    PubMed 19806256
  10. Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
    A complex role of activin A in non-alcoholic fatty liver disease
    Am J Gastroenterol, 104 (9), 2196-205
    PubMed 19532130
  11. Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
    Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
    Eur Heart J, 30 (10), 1229-36
    PubMed 19329498
  12. Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
    Elevated levels of activin A in clinical and experimental pulmonary hypertension
    J Appl Physiol, 106 (4), 1356-64
    PubMed 19196915
  13. Yndestad A, Neurauter CG, Oie E, Forstrøm RJ, Vinge LE, Eide L, Luna L, Aukrust P, Bjørås M (2009)
    Up-regulation of myocardial DNA base excision repair activities in experimental heart failure
    Mutat Res, 666 (1-2), 32-8
    PubMed 19481677

Publications 2008

  1. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK (2008)
    Chemokines and cardiovascular risk
    Arterioscler Thromb Vasc Biol, 28 (11), 1909-19
    PubMed 18669888
  2. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B (2008)
    The complex role of T-cell-based immunity in atherosclerosis
    Curr Atheroscler Rep, 10 (3), 236-43
    PubMed 18489852
  3. Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P (2008)
    A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
    Arterioscler Thromb Vasc Biol, 28 (5), 1005-11
    PubMed 18276907
  4. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
    Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
    Eur J Heart Fail, 10 (4), 352-9
    PubMed 18353719
  5. Husberg C, Nygård S, Finsen AV, Damås JK, Frigessi A, Oie E, Waehre A, Gullestad L, Aukrust P, Yndestad A, Christensen G (2008)
    Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
    J Mol Cell Cardiol, 45 (2), 261-9
    PubMed 18585734
  6. Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, Dahl CP, Pedersen TM, Ueland T, Gullestad L, Brosstad FR, Aukrust P, Damås JK (2008)
    Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
    Am J Respir Crit Care Med, 177 (2), 202-7
    PubMed 17962639
  7. Rolseth V, Rundén-Pran E, Neurauter CG, Yndestad A, Luna L, Aukrust P, Ottersen OP, Bjørås M (2008)
    Base excision repair activities in organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation
    DNA Repair (Amst), 7 (6), 869-78
    PubMed 18406215
  8. Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
    High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
    Cardiovasc Res, 79 (1), 195-203
    PubMed 18339644
  9. Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
    Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
    Am Heart J, 155 (1), 55.e1-9
    PubMed 18082489

Publications 2007

  1. Aukrust P, Yndestad A, Damås JK, Ueland T, Øie E, Gullestad L (2007)
    Potential mechanisms of benefit with thalidomide in chronic heart failure
    Am J Cardiovasc Drugs, 7 (2), 127-34
    PubMed 17503883
  2. Aukrust P, Yndestad A, Sandberg WJ, Gullestad L, Damås JK (2007)
    T cells in coronary artery disease: different effects of different T-cell subsets
    J Am Coll Cardiol, 50 (15), 1459-61
    PubMed 17919565
  3. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damås JK (2007)
    Chemokines in cardiovascular risk prediction
    Thromb Haemost, 97 (5), 748-54
    PubMed 17479185
  4. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
    Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
    Circulation, 115 (8), 972-80
    PubMed 17283255
  5. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2007)
    Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
    Arterioscler Thromb Vasc Biol, 27 (3), 614-20
    PubMed 17170367
  6. Fevang B, Yndestad A, Sandberg WJ, Holm AM, Müller F, Aukrust P, Frøland SS (2007)
    Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo
    Clin Exp Immunol, 147 (3), 521-5
    PubMed 17302902
  7. Gullestad L, Oie E, Ueland T, Yndestad A, Aukrust P (2007)
    The role of statins in heart failure
    Fundam Clin Pharmacol, 21 Suppl 2, 35-40
    PubMed 18001320
  8. Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P (2007)
    Role of inflammation in the progression of heart failure
    Curr Cardiol Rep, 9 (3), 236-41
    PubMed 17470337

Publications 2006

  1. Andersen GO, Oie E, Vinge LE, Yndestad A, Attramadal H, Skomedal T, Osnes JB (2006)
    Increased expression and function of the myocardial Na-K-2Cl cotransporter in failing rat hearts
    Basic Res Cardiol, 101 (6), 471-8
    PubMed 16783486
  2. Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L (2006)
    The role of intravenous immunoglobulin in the treatment of chronic heart failure
    Int J Cardiol, 112 (1), 40-5
    PubMed 16893578
  3. Aukrust P, Yndestad A, Ueland T, Damås JK, Gullestad L (2006)
    Anti-inflammatory trials in chronic heart failure
    Heart Fail Monit, 5 (1), 2-9
    PubMed 16547529
  4. Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
    Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
    J Immunol, 177 (4), 2699-706
    PubMed 16888032
  5. Florholmen G, Halvorsen B, Beraki K, Lyberg T, Sagen EL, Aukrust P, Christensen G, Yndestad A (2006)
    Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor
    J Mol Cell Cardiol, 41 (4), 689-97
    PubMed 16926021
  6. Halvorsen B, Waehre T, Scholz H, Damås JK, Yndestad A, Aukrust P (2006)
    Role of interleukin-10 in atherogenesis and plaque stabilization
    Future Cardiol, 2 (1), 75-83
    PubMed 19804134
  7. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
    Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
    Clin Exp Immunol, 144 (3), 418-24
    PubMed 16734610
  8. Holven KB, Damås JK, Yndestad A, Waehre T, Ueland T, Halvorsen B, Heggelund L, Sandberg WJ, Semb AG, Frøland SS, Ose L, Nenseter MS, Aukrust P (2006)
    Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
    Arterioscler Thromb Vasc Biol, 26 (1), 200-5
    PubMed 16254204
  9. Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, Stang E, Endresen K, Solum NO, Aukrust P, Damås JK (2006)
    Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes
    Blood, 108 (3), 928-35
    PubMed 16861346
  10. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
    Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
    Arterioscler Thromb Vasc Biol, 26 (4), 857-63
    PubMed 16424351
  11. Smith C, Damås JK, Otterdal K, Øie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Frøland SS, Hansson GK, Aukrust P (2006)
    Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
    J Am Coll Cardiol, 48 (8), 1591-9
    PubMed 17045893
  12. Ueland T, Aukrust P, Damas JK, Gullestad L, Yndestad A (2006)
    The tumor necrosis factor superfamily in heart failure
    Future Cardiol, 2 (1), 101-11
    PubMed 19804137
  13. Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
    Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
    J Thromb Haemost, 4 (10), 2140-7
    PubMed 16856976
  14. Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006)
    Systemic inflammation in heart failure--the whys and wherefores
    Heart Fail Rev, 11 (1), 83-92
    PubMed 16819581
  15. Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E (2006)
    Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
    Eur J Heart Fail, 8 (8), 790-6
    PubMed 16549389

Publications 2005

  1. Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A (2005)
    Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications
    Ann Med, 37 (2), 74-85
    PubMed 16026115
  2. Aukrust P, Yndestad A, Smith C, Sandberg WJ, Ueland T, Waehre T, Halvorsen B, Gullestad L, Damås JK (2005)
    Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation
    Expert Opin Pharmacother, 6 (13), 2169-80
    PubMed 16218879
  3. Aukrust P, Yndestad A, Waehre T, Gullestad L, Halvorsen B, Damås JK (2005)
    Inflammation in coronary artery disease: potential role for immunomodulatory therapy
    Expert Rev Cardiovasc Ther, 3 (6), 1111-24
    PubMed 16293001
  4. Dyrøy E, Yndestad A, Ueland T, Halvorsen B, Damås JK, Aukrust P, Berge RK (2005)
    Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways
    Arterioscler Thromb Vasc Biol, 25 (7), 1364-9
    PubMed 15920037
  5. Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P (2005)
    Agents targeting inflammation in heart failure
    Expert Opin Investig Drugs, 14 (5), 557-66
    PubMed 15926863
  6. Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
    Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
    Circulation, 112 (22), 3408-14
    PubMed 16301340
  7. Gurantz D, Yndestad A, Halvorsen B, Lunde OV, Omens JH, Ueland T, Aukrust P, Moore CD, Kjekshus J, Greenberg BH (2005)
    Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
    Cardiovasc Res, 67 (1), 106-15
    PubMed 15949474
  8. Overland G, Stuestøl JF, Dahle MK, Myhre AE, Netea MG, Verweij P, Yndestad A, Aukrust P, Kullberg BJ, Warris A, Wang JE, Aasen AO (2005)
    Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases
    Scand J Immunol, 62 (2), 148-54
    PubMed 16101821
  9. Scholz H, Sandberg W, Damås JK, Smith C, Andreassen AK, Gullestad L, Frøland SS, Yndestad A, Aukrust P, Halvorsen B (2005)
    Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis
    Circulation, 112 (14), 2121-9
    PubMed 16186421
  10. Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Frøland SS (2005)
    Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro
    Clin Exp Immunol, 140 (2), 376-83
    PubMed 15807865
  11. Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK (2005)
    Soluble CD40 ligand in acute and chronic heart failure
    Eur Heart J, 26 (11), 1101-7
    PubMed 15716285
  12. Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005)
    Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
    Circulation, 111 (19), 2461-8
    PubMed 15883214
  13. Øie E, Vinge LE, Andersen GØ, Yndestad A, Krobert KA, Sandberg C, Ahmed MS, Haug T, Levy FO, Skomedal T, Attramadal H (2005)
    RAMP2 and RAMP3 mRNA levels are increased in failing rat cardiomyocytes and associated with increased responsiveness to adrenomedullin
    J Mol Cell Cardiol, 38 (1), 145-51
    PubMed 15623431

Publications 2004

  1. Ahmed MS, Øie E, Vinge LE, Yndestad A, Øystein Andersen G, Andersson Y, Attramadal T, Attramadal H (2004)
    Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats
    J Mol Cell Cardiol, 36 (3), 393-404
    PubMed 15010278
  2. Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
    Therapeutic potential of anticytokine therapy in congestive heart failure
    Am J Cardiovasc Drugs, 4 (3), 169-77
    PubMed 15134469
  3. Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
    Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin
    Autoimmun Rev, 3 (3), 221-7
    PubMed 15110235
  4. Bjerkeli V, Halvorsen B, Damås JK, Nordøy I, Yndestad A, Aukrust P, Frøland SS (2004)
    Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
    Ann Rheum Dis, 63 (12), 1659-63
    PubMed 15547092
  5. Damås JK, Otterdal K, Yndestad A, Aass H, Solum NO, Frøland SS, Simonsen S, Aukrust P, Andreassen AK (2004)
    Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells
    Circulation, 110 (8), 999-1005
    PubMed 15302794
  6. Florholmen G, Andersson KB, Yndestad A, Austbø B, Henriksen UL, Christensen G (2004)
    Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism
    Acta Physiol Scand, 180 (2), 133-42
    PubMed 14738472
  7. Heggelund L, Damas JK, Yndestad A (2004)
    Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences. (vol 138, pg 116, 2004)
    Clin. Exp. Immunol., 138 (3), 554
  8. Heggelund L, Damås JK, Yndestad A, Holm AM, M?ller F, Lien E, Espevik T, Aukrust P, Frøland SS (2004)
    Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences
    Clin Exp Immunol, 138 (1), 116-21
    PubMed 15373913
  9. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
    Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
    Clin Infect Dis, 39 (2), 264-9
    PubMed 15307037
  10. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
    Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
    Clin Exp Immunol, 138 (2), 278-89
    PubMed 15498038
  11. Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Frøland SS, Aukrust P, Taskén K (2004)
    Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP
    AIDS, 18 (2), 171-9
    PubMed 15075533
  12. Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
    The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
    Endocrinology, 145 (11), 5177-84
    PubMed 15284208
  13. Scholz H, Aukrust P, Damås JK, Tonstad S, Sagen EL, Kolset SO, Hall C, Yndestad A, Halvorsen B (2004)
    8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
    Eur J Clin Invest, 34 (7), 451-8
    PubMed 15255781
  14. Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P (2004)
    Potential anti-inflammatory role of activin A in acute coronary syndromes
    J Am Coll Cardiol, 44 (2), 369-75
    PubMed 15261933
  15. Waehre T, Damås JK, Yndestad A, Taskén K, Pedersen TM, Smith C, Halvorsen B, Frøland SS, Solum NO, Aukrust P (2004)
    Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2
    Thromb Haemost, 92 (6), 1358-67
    PubMed 15583745
  16. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK (2004)
    Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
    Circulation, 109 (16), 1966-72
    PubMed 15051633
  17. Wang JE, Dahle MK, Yndestad A, Bauer I, McDonald MC, Aukrust P, Foster SJ, Bauer M, Aasen AO, Thiemermann C (2004)
    Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat
    Crit Care Med, 32 (2), 546-52
    PubMed 14758177
  18. Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P (2004)
    Elevated levels of activin A in heart failure: potential role in myocardial remodeling
    Circulation, 109 (11), 1379-85
    PubMed 14993131

Publications 2003

  1. Ahmed MS, Øie E, Vinge LE, Yndestad A, Andersen G GØ, Andersson Y, Attramadal T, Attramadal H (2003)
    Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism
    Cardiovasc Res, 60 (3), 557-68
    PubMed 14659801
  2. Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P (2003)
    Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets
    Circulation, 107 (21), 2670-6
    PubMed 12742982
  3. Reichelt WH, Yndestad A, Wright MS, Elgjo K, Haug T, Reichelt KL (2003)
    The colon mitosis-inhibitor pyroglutamyl-histidyl-glycine alters expression of immediate-early cancer-related genes in HT-29 cells
    Anticancer Res, 23 (2B), 1229-34
    PubMed 12820376
  4. Scholz H, Yndestad A, Damås JK, Waehre T, Tonstad S, Aukrust P, Halvorsen B (2003)
    8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
    Cardiovasc Res, 59 (4), 945-54
    PubMed 14553834
  5. Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås JK, Aukrust P, Frøland SS (2003)
    Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients
    Clin Exp Immunol, 132 (3), 462-6
    PubMed 12780693
  6. Ueland T, Odgren PR, Yndestad A, Godang K, Schreiner T, Marks SC, Bollerslev J (2003)
    Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over
    Bone, 33 (4), 638-45
    PubMed 14555269
  7. Ueland T, Sikkeland LI, Yndestad A, Eiken HG, Holm T, Guevara C, Haug T, Endresen K, Frøland SS, Gullestad L, Andreassen AK, Geiran O, Simonsen S, Aukrust P (2003)
    Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
    Am J Cardiol, 92 (6), 715-7
    PubMed 12972116
  8. Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
    Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    Cardiovasc Res, 60 (1), 141-6
    PubMed 14522416
  9. Øverland G, Morath S, Yndestad A, Hartung T, Thiemermann C, Foster SJ, Smedsrød B, Mathisen Ø, Aukrust P, Aasen AO, Wang JE (2003)
    Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro
    Surg Infect (Larchmt), 4 (2), 181-91
    PubMed 12906718

Publications 2002

  1. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
    Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
    Circulation, 106 (1), 36-42
    PubMed 12093767
  2. Gullestad L, Semb AG, Holt E, Skårdal R, Ueland T, Yndestad A, Frøland SS, Aukrust P (2002)
    Effect of thalidomide in patients with chronic heart failure
    Am Heart J, 144 (5), 847-50
    PubMed 12422154
  3. Oie E, Clausen OP, Yndestad A, Grøgaard HK, Attramadal H (2002)
    Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats
    Scand Cardiovasc J, 36 (2), 108-16
    PubMed 12028875
  4. Oie E, Yndestad A, Robins SP, Børnerheim R, Asberg A, Attramadal H (2002)
    Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats
    Basic Res Cardiol, 97 (3), 239-47
    PubMed 12061394
  5. Oije E, Clausen OPF, Yndestad A, Grogaard HK, Attramadal H (2002)
    Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats
    Scand. Cardiovasc. J., 36 (2), 108-116
  6. Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damås JK, Haug T, Eiken HG, Aukrust P, Frøland SS (2002)
    Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients
    Clin Exp Immunol, 130 (2), 279-85
    PubMed 12390316
  7. Waehre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P (2002)
    Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
    Eur J Clin Invest, 32 (11), 803-10
    PubMed 12423320
  8. Yndestad A, Damås JK, Geir Eiken H, Holm T, Haug T, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2002)
    Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
    Cardiovasc Res, 54 (1), 175-82
    PubMed 12062373

Publications 2001

  1. Eiken HG, Øie E, Damås JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tønnessen T, Christensen G, Frøland SS, Gullestad L, Attramadal H, Aukrust P (2001)
    Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
    Eur J Clin Invest, 31 (5), 389-97
    PubMed 11380590

Publications 2000

  1. Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P (2000)
    Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
    Cardiovasc Res, 47 (4), 778-87
    PubMed 10974226
  2. Oie E, Vinge LE, Yndestad A, Sandberg C, Grøgaard HK, Attramadal H (2000)
    Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats
    Circulation, 101 (4), 415-22
    PubMed 10653834
 
[230 visits]
>> Go back   >> Print this page   >> E-mail this page